Preventive surgeries could benefit at-risk women

08/31/2010 | HealthDay News

U.S. researchers found that women with mutations in the BRCA1 or BRCA2 genes that increase the risk of breast and ovarian cancer had a 70% to 80% lower risk of dying of the diseases after undergoing preventive mastectomy or having their ovaries and fallopian tubes removed. The study showed that women who underwent mastectomies had no breast cancer during the follow-up period, compared with a diagnosis of breast cancer in 7% of women who didn't have surgery.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park